Clene Inc.
CLNN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001822791
No open-market purchases or sales by Clene Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $19.6M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Clene Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 35 | 39 | +4 |
| Shares | 4.59M | 5.52M | +930.5K (+20.3%) |
| Value | $51.6M | $37.8M | −$13.8M (−26.8%) |
New holders (6)
Institutions that held Clene Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Soltis Investment Advisors LLC | 218,920 | $1.50M | 0.23% |
| HRT Financial LP | 48,840 | $333.0K | 0.00% |
| Morgan Jess S & Co Inc | 29,750 | $203.0K | 0.13% |
| Citadel Advisors LLC | 20,594 | $140.0K | 0.00% |
| Susquehanna International Group, LLP | 18,277 | $125.0K | 0.00% |
| Rockefeller Capital Management L.P. | 1,000 | $6.00K | 0.00% |
Sold out (2)
Institutions that held Clene Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Manufacturers Life Insurance Company, The | 13,393 | $151.0K |
| Pinz Capital Management, LP | 6,292 | $71.0K |